MD Medical Group Investments Plc

MD Medical Group Investments Plc

MDMG.ME
MD Medical Group Investments PlcRU flagMoscow Stock Exchange
1,203.50
RUB
+0.50
- -
90.41BMarket Cap
MD Medical Group Investments Plc
MDMG.ME
(Moscow Stock Exchange)

Recent

price

1,203.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
FRC
0.02
0.03
46.52
62.27
75.51
95.97
126.94
162.62
183.66
199.11
215.12
254.69
335.7
335.73
Revenue per Share
0.01
0.01
13.76
21.46
8.47
15.94
21.41
27.58
33.23
35.61
35.11
55.86
79.91
60.7
Basic EPS, GAAP
0.01
0.01
-11.96
-12.72
-10.25
-13.7
27.11
28.22
9.66
4.79
12.69
34.75
62.68
87.38
Free Cash Flow per Basic Share
- -
- -
0.02
2.36
4.18
2.4
4.01
10.49
9.09
6.59
10.5
29.43
36.3
8.48
Dividend per Share
- -
- -
2.39
2.77
54.73
69.83
87.36
103.85
127.62
148.13
172.4
199.94
242.86
295.01
Book Value per Share
- -
- -
44.42
131.75
116.57
108.69
125.04
137.91
163.32
183.15
208.83
236.23
278.94
332.82
Tangible Book Value per Share
72,125
72,125
63
65
75
75
75
75
75
75
75
75
75
75
Basic Weighted Avg Shares
1,790
2,044
2,908
4,061
5,673
7,201
9,507
12,179
13,755
14,937
16,160
19,133
25,220
25,222
Sales/Revenue/Turnover
46.39
46.8
41.03
38.42
20.42
21.33
18.67
22.36
23.45
20.13
19.82
22.58
26.36
24.72
Operating Margin (%)
125
132
99
134
428
547
881
946
1,036
1,190
1,509
1,524
1,699
1,668
Depreciation Expense
535
698
860
1,399
636
1,196
1,604
2,066
2,489
2,671
2,638
4,196
6,003
4,560
Net Income, GAAP
20.17
20.25
22.69
- -
8.6
5.39
1.91
- -
2.77
0.91
- -
0.11
0.25
0.16
Effective Tax Rate (%)
29.92
34.15
29.58
34.46
11.21
16.6
16.87
16.96
18.09
17.88
16.32
21.93
23.8
18.08
Profit Margin (%)
- -
- -
-589
3,842
1,569
-1,115
-529
-756
33
197
779
213
-641
2,074
Working Capital
- -
- -
1,060
2,696
2,380
3,251
2,300
2,200
3,585
4,587
5,864
5,230
3,727
489
LT Debt
- -
- -
2,807
8,623
9,209
10,137
11,509
12,770
14,568
15,999
17,880
19,953
23,097
26,963
Total Equity
- -
- -
46.02
- -
8.9
10.99
11.92
- -
17.85
14.66
- -
16.75
24.06
22.31
Return on Invested Capital (%)
- -
- -
101.98
- -
13.9
15.63
17.82
- -
19.64
18.29
- -
21.33
27.51
20.35
Return on Capital (%)
- -
- -
1,149.43
847.58
29.64
25.57
27.22
28.85
28.71
25.85
21.92
30.01
36.09
22.57
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.11%
13.14%
16.74%
Free Cash Flow
7.58%
81.75%
39.4%
Net Income, GAAP
20.1%
16.84%
-24.04%
Sales/Revenue/Turnover
20.67%
13.4%
0.01%
Total Cash Common Dividend
43.57%
31.83%
-76.65%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
25,220
2022
- -
- -
- -
- -
25,222
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
79.91
2022
- -
- -
- -
- -
60.7
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
36.3
2022
- -
- -
- -
- -
8.48
2023
- -
- -
- -
- -
- -
Business
MD Medical Group Investments Plc (MDMG.ME) operates as a private healthcare provider in Russia, offering a comprehensive range of medical services through its network of multidisciplinary clinics under the Mother and Child brand; these services encompass reproductive medicine and IVF programs, pediatrics, obstetrics and gynecology, surgical interventions, diagnostic imaging, laboratory testing, and specialized treatments for women and children. The company delivers high-quality outpatient and inpatient care, including maternity services, neonatal intensive care, and genetic counseling, targeting families, expectant mothers, and pediatric patients across its primary markets in Russia. Founded in 2006 and headquartered in Moscow, the group maintains operations predominantly in major Russian cities such as Moscow, St. Petersburg, and regional centers, with no significant international presence noted. In recent developments within the last two years, MD Medical Group has focused on network expansion through organic clinic openings and operational enhancements amid challenging market conditions; no major acquisitions, funding rounds, or strategic partnerships have been publicly announced recently, reflecting a steady emphasis on core healthcare delivery rather than transformative changes. The company functions as a standalone entity listed on the Moscow Exchange, serving as a key player in Russia's competitive private medical sector.